[6] YAMAMOTO, RYOHEI, IMAI, ENYU, MARUYAMA, SHOICHI, et al. Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study[J]. Journal of nephrology.,2022,35(4):1135-1144.
[13] PHILIPPE RÉMY, VINCENT AUDARD, PIERRE ANDRÉ NATELLA, et al. An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study)[J]. Kidney international.,2018,94(6):1217-1226.